We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
-29.17%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$122M
AUM Growth
-$127M
(-51%)
Cap. Flow
-$58.3M
Cap. Flow
% of AUM
-47.69%
Top 10 Holdings %
Top 10 Hldgs %
25.43%
Holding
188
New
64
Increased
19
Reduced
68
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The RMR Group
RMR
|
+$4.54M |
| 2 |
InterDigital
IDCC
|
+$4.48M |
| 3 |
Stride
LRN
|
+$4.07M |
| 4 |
Strategy Inc
MSTR
|
+$2.79M |
| 5 |
Valvoline
VVV
|
+$2.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JetBlue
JBLU
|
+$6.96M |
| 2 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$5.53M |
| 3 |
Bausch Health
BHC
|
+$4.16M |
| 4 |
Raymond James Financial
RJF
|
+$4.11M |
| 5 |
Applied Industrial Technologies
AIT
|
+$3.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.23% |
| 2 | Consumer Discretionary | 15.57% |
| 3 | Industrials | 12.32% |
| 4 | Healthcare | 9.67% |
| 5 | Communication Services | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Belden
BDC
$5.28B
| $1.49M | 1.22% |
41,314
-51,422
| -55% | -$2.36M |
|
|
27
Bausch Health
BHC
$2.37B
| $1.47M | 1.2% |
95,041
-172,699
| -65% | -$4.16M |
|
28
LKQ Corp
LKQ
$6.22B
| $1.45M | 1.18% |
70,555
-29,860
| -30% | -$885K |
|
|
DHIL
29
DELISTED
Diamond Hill
DHIL
| $1.42M | 1.16% |
15,712
-13,949
| -47% | -$1.76M |
|
30
CVS Health
CVS
$122B
| $1.35M | 1.1% |
22,718
-38,000
| -63% | -$2.54M |
|
31
Spok Holdings
SPOK
$237M
| $1.3M | 1.07% |
121,916
-97,607
| -44% | -$1.05M |
|
|
FL
32
DELISTED
Foot Locker
FL
| $1.27M | 1.04% |
57,473
-41,020
| -42% | -$1.39M |
|
|
TESS
33
DELISTED
Tessco Technologies Inc
TESS
| $1.23M | 1.01% |
251,779
+128,317
| +104% | +$949K |
|
34
Goldman Sachs
GS
$301B
| $1.23M | 1% |
7,928
-5,369
| -40% | -$1.14M |
|
35
Owens Corning
OC
$12.2B
| $1.22M | 0.99% |
31,306
-17,653
| -36% | -$988K |
|
36
F5
FFIV
$23.2B
| $1.21M | 0.99% |
+11,308
| New | +$1.38M |
|
37
Orion
OEC
$389M
| $1.19M | 0.97% |
159,830
-91,182
| -36% | -$1.32M |
|
38
Mitek Systems
MITK
$837M
| $1.16M | 0.95% |
147,765
-189,778
| -56% | -$1.61M |
|
|
39
Raymond James Financial
RJF
$34.5B
| $1.1M | 0.9% |
26,142
-72,876
| -74% | -$4.11M |
|
40
Harvard Bioscience
HBIO
$28.8M
| $1.09M | 0.89% |
49,156
-20,055
| -29% | -$543K |
|
|
GRA
41
DELISTED
W.R. Grace & Co.
GRA
| $1.08M | 0.88% |
+30,329
| New | +$1.73M |
|
42
Sanmina
SANM
$10.7B
| $1.08M | 0.88% |
39,490
-72,369
| -65% | -$2.11M |
|
43
Titan Machinery
TITN
$426M
| $1.01M | 0.82% |
116,069
-50,700
| -30% | -$576K |
|
44
Moog Inc Class A
MOG.A
$13B
| $991K | 0.81% |
+19,613
| New | +$1.52M |
|
45
Ameren
AEE
$29.6B
| $986K | 0.81% |
+13,540
| New | +$1.07M |
|
46
Weyco Group
WEYS
$441M
| $984K | 0.8% |
48,792
-392
| -0.8% | -$8.79K |
|
47
FirstEnergy
FE
$27.1B
| $974K | 0.8% |
+24,318
| New | +$1.13M |
|
48
Cabot Corp
CBT
$4.46B
| $915K | 0.75% |
35,034
-29,255
| -46% | -$1.11M |
|
49
HCA Healthcare
HCA
$89.6B
| $906K | 0.74% |
+10,086
| New | +$1.31M |
|
50
Flexsteel Industries
FLXS
$307M
| $898K | 0.73% |
81,973
-4,087
| -5% | -$63.6K |
|
Similar funds
SIG
CAG
ORCP
ET
GC
MIAS
TAL
IIP
Invenomic Capital Management's Q1 2020 Portfolio in Review
As of Q1 2020, Invenomic Capital Management held 188 positions worth $122M, down 51% from $249M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Invenomic Capital Management withdrew a net $58.3M in Q1 2020, closing 36 positions and reducing 68 holdings. Its most notable exit was JetBlue, an estimated $6.96M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Invenomic Capital Management opened a new position in The RMR Group worth $3.16M.
- Invenomic Capital Management's largest Q1 2020 buy was The RMR Group: 117,245 shares worth $3.16M.
- Invenomic Capital Management added most to UGI in Q1 2020, an estimated $1.26M increase.
- Invenomic Capital Management's biggest Q1 2020 reduction was Bausch Health, cutting an estimated $4.16M.
- Invenomic Capital Management fully exited JetBlue in Q1 2020, selling an estimated $6.96M.
- Invenomic Capital Management's ten largest holdings make up 25% of its $122M portfolio in Q1 2020.
- Invenomic Capital Management opened 64 new positions and closed 36 in Q1 2020.
- Invenomic Capital Management's portfolio value fell 51% quarter-over-quarter to $122M.
Based on Invenomic Capital Management's 13F filing for Q1 2020, filed 13 May 2020.